<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>28(11)</volume><submitter>Nguyen NN</submitter><pubmed_abstract>We describe 188 patients in France who were successively infected with different SARS-CoV-2 Omicron subvariants, including BA.1, BA.2, and BA.5. Time between 2 infections was &lt;90 days for 50 (26.6%) patients and &lt;60 days for 28 (14.9%) patients. This finding suggests that definitions for SARS-CoV-2 reinfection require revision.</pubmed_abstract><journal>Emerging infectious diseases</journal><pagination>2341-2343</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9622229</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Reinfections with Different SARS-CoV-2 Omicron Subvariants, France.</pubmed_title><pmcid>PMC9622229</pmcid><pubmed_authors>Nguyen NN</pubmed_authors><pubmed_authors>Colson P</pubmed_authors><pubmed_authors>Gautret P</pubmed_authors><pubmed_authors>Delorme L</pubmed_authors><pubmed_authors>Houhamdi L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reinfections with Different SARS-CoV-2 Omicron Subvariants, France.</name><description>We describe 188 patients in France who were successively infected with different SARS-CoV-2 Omicron subvariants, including BA.1, BA.2, and BA.5. Time between 2 infections was &lt;90 days for 50 (26.6%) patients and &lt;60 days for 28 (14.9%) patients. This finding suggests that definitions for SARS-CoV-2 reinfection require revision.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-04T07:45:19.844Z</modification><creation>2025-04-04T07:45:19.844Z</creation></dates><accession>S-EPMC9622229</accession><cross_references><pubmed>36150518</pubmed><doi>10.3201/eid2811.221109</doi></cross_references></HashMap>